Autophagy dysfunction may be involved in the pathogenesis of ankylosing spondylitis

被引:24
|
作者
Tan, Min [1 ]
Zhang, Quan-Bo [1 ]
Liu, Tao-Hong [1 ]
Yang, Yan-Yu [1 ]
Zheng, Jian-Xiong [2 ]
Zhou, Wen-Jun [2 ]
Xiong, Qin [1 ]
Qing, Yu-Feng [2 ]
机构
[1] North Sichuan Med Coll, Dept Geriatr, Affiliated Hosp, 63 Wenhua Rd, Nanchong 637000, Sichuan, Peoples R China
[2] North Sichuan Med Coll, Dept Rheumatol & Immunol, Affiliated Hosp, 63 Wenhua Rd, Nanchong 637000, Sichuan, Peoples R China
关键词
ankylosing spondylitis; autophagy-related genes; long non-coding RNA growth arrest-specific 5; diagnosis; disease severity and activity; ER STRESS; EXPRESSION; INHIBITION; ACTIVATION; AUTOIMMUNE; HOMOLOG; IL-23; GAS5; FLUX;
D O I
10.3892/etm.2020.9116
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The present study aimed to investigate the expression and significance of the mRNA of genes associated with autophagy and long non-coding RNA (lncRNA) GAS5 in peripheral blood mononuclear cells (PBMCs) of patients with ankylosing spondylitis (AS). The mRNA levels of microtubule-associated protein light chain 3 (LC3), Beclin1, autophagy-related gene (ATG)3, ATG5, ATG12, ATG 16 ligand 1 (ATG16L1) and lncRNA growth arrest-specific 5 (GAS5) in PBMCs from 60 patients with AS and 30 healthy controls (HC) were examined by reverse transcription-quantitative PCR. The correlations between the levels of LC3, Beclin1, ATG3, ATG5, ATG12 and ATG16L1 mRNA as well as lncRNA GAS5 levels with disease activity and laboratory parameters in patients with AS were determined by Spearman correlation analysis. In addition, the diagnostic value of lncRNA GAS5 for AS was explored through establishing a receiver operating characteristic (ROC) curve. The results indicated that, compared to the HCs, patients with AS had lower expression levels of LC3, ATG5, ATG12, ATG16L1 and lncRNA GAS5 in their PBMCs. Compared with those in patients with inactive AS, the levels of ATG5 and ATG12 were lower than those in patients with active AS. Of note, ATG5 and ATG12 mRNA levels were negatively correlated with disease activity indexes. lncRNA GAS5 was positively correlated with the expression of Beclin1, ATG3, ATG5, ATG12 and ATG16L1. The area under the ROC curve for the use of lncRNA GAS5 expression to diagnose AS was 0.808 with a 95% CI of 0.714-0.902. In conclusion, patients with AS had decreased expression of genes associated with autophagy and lncRNA GAS5. The extent of the reduction in ATG5 and ATG12 expression levels in patients with AS was correlated with the disease severity and activity. Furthermore, lncRNA GAS5 was a diagnostic indicator of AS.
引用
收藏
页码:3578 / 3586
页数:9
相关论文
共 50 条
  • [31] Evaluation of Sexual Dysfunction in Females With Ankylosing Spondylitis
    Akkurt, Halil Ekrem
    Yilmaz, Halim
    Yilmaz, Sema
    Parlak, Lutfiye
    Ordahan, Banu
    Salli, Ali
    ARCHIVES OF RHEUMATOLOGY, 2016, 31 (01): : 41 - 47
  • [32] Atherosclerosis and endothelial dysfunction in patients with ankylosing spondylitis
    Azevedo, V. F.
    Pecoits-Filho, R.
    RHEUMATOLOGY INTERNATIONAL, 2010, 30 (11) : 1411 - 1416
  • [33] Atherosclerosis and endothelial dysfunction in patients with ankylosing spondylitis
    V. F. Azevedo
    R. Pecoits-Filho
    Rheumatology International, 2010, 30 : 1411 - 1416
  • [34] Spironolactone improves endothelial dysfunction in ankylosing spondylitis
    Syngle, Ashit
    Vohra, Kanchan
    Khichi, Dinesh
    Garg, Nidhi
    Verma, Inderjeet
    Kaur, Ladbans
    CLINICAL RHEUMATOLOGY, 2013, 32 (07) : 1029 - 1036
  • [35] Rosuvastatin improves endothelial dysfunction in ankylosing spondylitis
    Nidhi Garg
    Pawan Krishan
    Ashit Syngle
    Clinical Rheumatology, 2015, 34 : 1065 - 1071
  • [36] Rosuvastatin improves endothelial dysfunction in ankylosing spondylitis
    Garg, Nidhi
    Krishan, Pawan
    Syngle, Ashit
    CLINICAL RHEUMATOLOGY, 2015, 34 (06) : 1065 - 1071
  • [37] Ankylosing spondylitis
    Malbos, Damien
    ACTUALITES PHARMACEUTIQUES, 2024, 63 (640): : 47 - 50
  • [38] Spironolactone improves endothelial dysfunction in ankylosing spondylitis
    Ashit Syngle
    Kanchan Vohra
    Dinesh Khichi
    Nidhi Garg
    Inderjeet Verma
    Ladbans Kaur
    Clinical Rheumatology, 2013, 32 : 1029 - 1036
  • [39] New developments in our understanding of ankylosing spondylitis pathogenesis
    Voruganti, Aniruddha
    Bowness, Paul
    IMMUNOLOGY, 2020, 161 (02) : 94 - 102
  • [40] Pathogenesis of ankylosing spondylitis -: mechanisms of disease manifestation and chronicity
    Märker-Hermann, E
    Frauendorf, E
    Zeidler, H
    Sieper, J
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2004, 63 (03): : 187 - 192